Cargando…

Dedicated call center (SOS-HAE) for hereditary angioedema attacks: study protocol for a randomised controlled trial

BACKGROUND: Despite the availability of guidelines for the specific treatment of hereditary angioedema (HAE) attacks, HAE morbidity and mortality rates remain substantial. HAE attacks are a major medical issue requiring specific treatment as well as a considerable socio-economic burden. We report a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Javaud, Nicolas, Fain, Olivier, Durand-Zaleski, Isabelle, Launay, David, Bouillet, Laurence, Gompel, Anne, Sobel, Alain, Woimant, Maguy, Rabetrano, Hasina, Petrovic, Tomislav, Lapostolle, Frédéric, Boccon-Gibod, Isabelle, Reuter, Paul-Georges, Bertrand, Philippe, Coppere, Brigitte, Floccard, Bernard, Kanny, Gisele, Martin, Ludovic, Vicaut, Eric, Adnet, Frédéric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853856/ https://www.ncbi.nlm.nih.gov/pubmed/27140403 http://dx.doi.org/10.1186/s13063-016-1350-0

Ejemplares similares

Hereditary angioedema with normal C1 inhibitor in a French cohort: Clinical characteristics and response to treatment with icatibant
por: Bouillet, Laurence, et al.
Publicado: (2017)

Long-term prophylaxis with lanadelumab for HAE: authorization for temporary use in France
por: Fain, Olivier, et al.
Publicado: (2022)

Profile of serious angioedema requiring an urgent advice from a national reference call center
por: Simon, Nicolas, et al.
Publicado: (2022)

Angioedema Related to Angiotensin-Converting Enzyme Inhibitors: Attack Severity, Treatment, and Hospital Admission in a Prospective Multicenter Study
por: Javaud, Nicolas, et al.
Publicado: (2015)

An evidence-based review of the potential role of icatibant in the treatment of acute attacks in hereditary angioedema type I and II
por: Floccard, Bernard, et al.
Publicado: (2012)

Attenuated androgen discontinuation in patients with hereditary angioedema: a commented case series
por: Maurer, Marcus, et al.
Publicado: (2022)

Glucocorticoids for acute urticaria: study protocol for a double-blind non-inferiority randomised controlled trial
por: Javaud, Nicolas, et al.
Publicado: (2019)

A nationwide study of acquired C1-inhibitor deficiency in France: Characteristics and treatment responses in 92 patients
por: Gobert, Delphine, et al.
Publicado: (2016)

Family Presence during Resuscitation: A Qualitative Analysis from a National Multicenter Randomized Clinical Trial
por: De Stefano, Carla, et al.
Publicado: (2016)

The symptom experience of hereditary angioedema (HAE) patients beyond HAE attacks: literature review and clinician interviews
por: Jean-Baptiste, Milenka, et al.
Publicado: (2022)

The Global Registry for Hereditary Angioedema due to C1-Inhibitor Deficiency
por: Zanichelli, Andrea, et al.
Publicado: (2021)

COVID-19 Epidemic: Chloroquine, a French Obsession?
por: Lapostolle, Fréderic, et al.
Publicado: (2021)

Paroxysmal Permeability Disorders: Development of a Microfluidic Device to Assess Endothelial Barrier Function
por: Wu, Maddalena Alessandra, et al.
Publicado: (2019)

The Icatibant Outcome Survey: experience of hereditary angioedema management from six European countries
por: Caballero, T., et al.
Publicado: (2017)

Measurement of Bradykinin Formation and Degradation in Blood Plasma: Relevance for Acquired Angioedema Associated With Angiotensin Converting Enzyme Inhibition and for Hereditary Angioedema Due to Factor XII or Plasminogen Gene Variants
por: Marceau, François, et al.
Publicado: (2020)

A national population-based study of patients, bystanders and contextual factors associated with resuscitation in witnessed cardiac arrest: insight from the french RéAC registry
por: Reuter, Paul-Georges, et al.
Publicado: (2021)

HAE international home therapy consensus document
por: Longhurst, Hilary J, et al.
Publicado: (2010)

Impact of COVID-19 pandemic on non-COVID-19 publications
por: Lapostolle, Frédéric, et al.
Publicado: (2021)

Impact of the COVID-19 epidemic on the incidence of acute myocardial infarction in Seine-Saint-Denis
por: Lapostolle, Frédéric, et al.
Publicado: (2020)

Hereditary angioedema (HAE) in children and adolescents—a consensus on therapeutic strategies
por: Wahn, V., et al.
Publicado: (2012)

Cost-effectiveness model for on-demand treatment of hereditary angioedema (HAE) attacks
por: Tyson, Christopher, et al.
Publicado: (2019)

Hereditary angioedema (HAE) in Belgium: results from a national survey
por: Van der Poorten, MM, et al.
Publicado: (2023)

Long-term Prophylaxis with Androgens in the management of Hereditary Angioedema (HAE) in emerging countries
por: Guo, Yinshi, et al.
Publicado: (2022)

Prevention of Recurrent Attacks of Hereditary Angioedema (HAE): Berotralstat and Its Oral Bioavailability
por: Diaz-Menindez, Maximiliano, et al.
Publicado: (2023)

Effectiveness and cost-effectiveness of telephone consultations for fever or gastroenteritis using a formalised procedure in general practice: study protocol of a cluster randomised controlled trial
por: Reuter, Paul-Georges, et al.
Publicado: (2016)

Intubating trauma patients before reaching hospital – revisited
por: Adnet, Frédéric, et al.
Publicado: (2001)

Expert perspectives on hereditary angioedema: Key areas for advancements in care across the patient journey
por: Banerji, Aleena, et al.
Publicado: (2016)

HAE therapies: past present and future
por: Zuraw, Bruce L
Publicado: (2010)

The hereditary angioedema burden of illness study in Europe (HAE-BOIS-Europe): background and methodology
por: Bygum, Anette, et al.
Publicado: (2012)

Lanadelumab Injection Treatment For The Prevention Of Hereditary Angioedema (HAE): Design, Development And Place In Therapy
por: Bova, Maria, et al.
Publicado: (2019)

A patient with hereditary angioedema (HAE) with normal C1-INH and SLE with pregnancy
por: Taha, Omar S., et al.
Publicado: (2022)

Icatibant use in Brazilian patients with hereditary angioedema (HAE) type 1 or 2 and HAE with normal C1-INH levels: findings from the Icatibant Outcome Survey Registry Study()
por: Grumach, Anete S., et al.
Publicado: (2022)

Clinical features of 1487 COVID-19 patients with outpatient management in the Greater Paris: the COVID-call study
por: Lapostolle, Frédéric, et al.
Publicado: (2020)

HAE patient self-sampling for biomarker establishment
por: Förster, Toni M., et al.
Publicado: (2021)

Norepinephrine weaning in septic shock patients by closed loop control based on fuzzy logic
por: Merouani, Mehdi, et al.
Publicado: (2008)

Long‐term safety of icatibant treatment of patients with angioedema in real‐world clinical practice
por: Zanichelli, A., et al.
Publicado: (2017)

Risk of angioedema following invasive or surgical procedures in HAE type I and II – the natural history
por: Aygören-Pürsün, E, et al.
Publicado: (2013)

Safety Aspects and Rational Use of Lanadelumab Injections in the Treatment of Hereditary Angioedema (HAE): Clinical Insights
por: Petkova, Elena, et al.
Publicado: (2022)

Laryngeal edema is common in HAE and demands preventive measures
por: Rosario, Cristine Secco, et al.
Publicado: (2015)

Screening for hereditary angioedema (HAE) at 13 emergency centers in Osaka, Japan: A prospective observational study
por: Hirose, Tomoya, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ccm2krnkgbljg9lu01tms8pvvb